AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33961650 — intervention group
Group type: EXPERIMENTAL
Intervention: TB cohort with comorbidities
Number of subjects: 6934
Study 33961650 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary cancer types in TB cohort
Number of subjects: 6934
Study 33225804 — intervention group
Group type: EXPERIMENTAL
Intervention: Online psychoeducation curriculum delivered via 5 to 10-minute videos over 8 weeks
Number of subjects: 29
Study 33225804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 29
Study 35723939 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin injections (24-unit dose individualized according to crow's feet line distribution)
Number of subjects: 323
Study 33479442 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB) with low-pressure pneumoperitoneum (PP) at 8 mmHg
Number of subjects: 74
Study 33479442 — intervention group
Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB) with high-pressure pneumoperitoneum (PP) at 12 mmHg
Number of subjects: 74
Study 33479442 — intervention group
Group type: COMPARATOR
Intervention: Moderate NMB group
Number of subjects: 74
Study 33479442 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep NMB group
Number of subjects: 74
Study 34412104 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 84 mg nasal spray plus standard of care
Number of subjects: 456
Study 34412104 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray plus standard of care
Number of subjects: 456
Study 33058957 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate (LC) diet: 14% energy carbohydrate, 28% protein, 58% fat (<10% saturated fat)
Number of subjects: 115
Study 33058957 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate (HC) diet: 53% carbohydrate, 17% protein, 30% fat (<10% saturated fat)
Number of subjects: 115
Study 33168360 — intervention group
Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy with disposable intraoral dental camera protection cap
Number of subjects: 12
Study 33168360 — intervention group
Group type: COMPARATOR
Intervention: Videolaryngoscopy without disposable intraoral dental camera protection cap
Number of subjects: 12
Study 33474952 — intervention group
Group type: EXPERIMENTAL
Intervention: New silicone drainage plug (model group)
Number of subjects: 74
Study 33474952 — intervention group
Group type: COMPARATOR
Intervention: Conventional plug (control group)
Number of subjects: 74
Study 33212907 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus HN001 probiotic
Number of subjects: 33
Study 33212907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 35123210 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol treatment
Number of subjects: 126
Study 35123210 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 126
Study 33094465 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Number of subjects: 30
Study 33094465 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercises
Number of subjects: 30
Study 33094465 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (Pilates + Aerobic exercises)
Number of subjects: 30
Study 34939776 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg per day
Number of subjects: 0
Study 34939776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32072695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrilite™ Multi Carotene supplement
Number of subjects: 60
Study 32072695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35445358 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma amyloid-beta (Aβ) alone
Number of subjects: 401
Study 35445358 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma amyloid-beta (Aβ) plus multiple plasma biomarkers
Number of subjects: 401
Study 35445358 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined assessment of Aβ, GDF15, and MCP1
Number of subjects: 401
Study 35685555 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care
Number of subjects: 80
Study 35685555 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 80
Study 34096993 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability to ADHD
Number of subjects: 0
Study 34096993 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic liability to ASD
Number of subjects: 0
Study 34096993 — intervention group
Group type: COMPARATOR
Intervention: Higher educational attainment (EA)
Number of subjects: 0
Study 36441522 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly oral doses of vitamin D3, 14,000 IU for 3 years
Number of subjects: 8851
Study 36441522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8851
Study 36441522 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 8851
Study 33998163 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 4 mg q.d.
Number of subjects: 195
Study 33998163 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients unwilling to take medication)
Number of subjects: 195
Study 32439926 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block (ESPB)
Number of subjects: 100
Study 34756607 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified technique
Number of subjects: 60
Study 34756607 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 60
Study 33881700 — intervention group
Group type: EXPERIMENTAL
Intervention: Moringa Oleifera leaves supplementation (MOG)
Number of subjects: 200
Study 33881700 — intervention group
Group type: COMPARATOR
Intervention: Control group (COG)
Number of subjects: 200
Study 35457686 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient empowerment (measured by DES-SF)
Number of subjects: 0
Study 35457686 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33491321 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Based Treatment (PBT)
Number of subjects: 150
Study 33491321 — intervention group
Group type: COMPARATOR
Intervention: Family-Based Treatment (FBT)
Number of subjects: 150
Study 33174856 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified problem-solving intervention delivered via telephone and 8 asynchronous online sessions.
Number of subjects: 240
Study 33174856 — intervention group
Group type: COMPARATOR
Intervention: Usual care group with no changes in information or discharge planning, access to existing VA resources.
Number of subjects: 240
Study 33174856 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified problem-solving intervention
Number of subjects: 240
Study 34536915 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.6 mg/kg rocuronium
Number of subjects: 66
Study 34536915 — intervention group
Group type: COMPARATOR
Intervention: Saline (no neuromuscular block)
Number of subjects: 66
Study 33602439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy after 3-month dual-antiplatelet therapy (DAPT)
Number of subjects: 1103
Study 33602439 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy after 3-month DAPT
Number of subjects: 1103
Study 33602439 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor-based 12-month DAPT
Number of subjects: 1103
Study 35325055 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day course of antibiotics
Number of subjects: 152
Study 35325055 — intervention group
Group type: COMPARATOR
Intervention: 24-h course of antibiotics
Number of subjects: 152
Study 34791911 — intervention group
Group type: EXPERIMENTAL
Intervention: Neck strengthening exerciser device (Group A)
Number of subjects: 58
Study 34791911 — intervention group
Group type: COMPARATOR
Intervention: Regular neck exercise (Group B)
Number of subjects: 58
Study 34342015 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI + SFAS
Number of subjects: 393
Study 34342015 — intervention group
Group type: COMPARATOR
Intervention: BMI + RT
Number of subjects: 393
Study 34342015 — intervention group
Group type: COMPARATOR
Intervention: AO
Number of subjects: 393
Study 36183567 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-administered intervention in NICU
Number of subjects: 153
Study 36183567 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 153
Study 33036254 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with poziotinib and manidipine
Number of subjects: 0
Study 35259151 — intervention group
Group type: EXPERIMENTAL
Intervention: Asibonisane Community Responses Program (Stepping Stones)
Number of subjects: 1528
Study 35259151 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline treatment levels for those living with HIV
Number of subjects: 1528
Study 35259151 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV testing in the last six months
Number of subjects: 1528
Study 34339623 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab (840 mg loading dose, then 420 mg every 3 weeks for pertuzumab; 8 mg/kg loading dose, then 6 mg/kg every 3 weeks for trastuzumab)
Number of subjects: 39
Study 34339623 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab
Number of subjects: 39
Study 34560813 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 149
Study 34560813 — intervention group
Group type: COMPARATOR
Intervention: Nondirective intervention
Number of subjects: 149
Study 32162420 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (4:1 ratio: buprenorphine 2 mg + naloxone 0.5 mg)
Number of subjects: 14
Study 32162420 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (2:1 ratio: buprenorphine 2 mg + naloxone 1 mg)
Number of subjects: 14
Study 32162420 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine and naloxone co‐formulation (1:1 ratio: buprenorphine 2 mg + naloxone 2 mg)
Number of subjects: 14
Study 32162420 — intervention group
Group type: COMPARATOR
Intervention: Buprenorphine alone (2 mg)
Number of subjects: 14
Study 32162420 — intervention group
Group type: COMPARATOR
Intervention: Pheniramine maleate (45.5 mg)
Number of subjects: 14
Study 32162420 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 14
Study 35839637 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS treatment (n = 29)
Number of subjects: 56
Study 35839637 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (n = 27)
Number of subjects: 56
Study 34126984 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride interventions (specific types and dosages not mentioned)
Number of subjects: 0
Study 34792177 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT)
Number of subjects: 211
Study 34792177 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (Zol)
Number of subjects: 211
Study 34792177 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 211
Study 34792177 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 211
Study 32924312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin surface cleaning
Number of subjects: 85
Study 32924312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin surface roughening with round bur plus flowable composite
Number of subjects: 85
Study 32924312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin surface roughening/cervical groove preparation with round bur
Number of subjects: 85
Study 32924312 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentin surface roughening/cervical groove preparation with round bur plus flowable composite
Number of subjects: 85
Study 32924312 — intervention group
Group type: COMPARATOR
Intervention: No preparation (cavity cleaning only)
Number of subjects: 85
Study 35822275 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital health technologies (three types)
Number of subjects: 200
Study 35822275 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study 33059755 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored psychological intervention plus usual care including referral to pulmonary rehabilitation (PR)
Number of subjects: 0
Study 33059755 — intervention group
Group type: COMPARATOR
Intervention: Usual care including referral to pulmonary rehabilitation (PR)
Number of subjects: 0
Study 33577167 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiation Therapy (SBRT)
Number of subjects: 0
Study 33577167 — intervention group
Group type: COMPARATOR
Intervention: Conventional Fractionation
Number of subjects: 0
Study 32142970 — intervention group
Group type: EXPERIMENTAL
Intervention: Watermelon puree (100% daily for 6 weeks)
Number of subjects: 0
Study 32142970 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 36356913 — intervention group
Group type: COMPARATOR
Intervention: Covert ordering intervention (products ordered by carbon footprint without explicit information)
Number of subjects: 1842
Study 36356913 — intervention group
Group type: COMPARATOR
Intervention: Overt ordering intervention (products ordered by carbon footprint with explicit information)
Number of subjects: 1842
Study 36356913 — intervention group
Group type: COMPARATOR
Intervention: Control arm (products randomly ordered)
Number of subjects: 1842
Study 34264943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention stores (moved 26 meat-free products into the meat aisle)
Number of subjects: 108
Study 34264943 — intervention group
Group type: COMPARATOR
Intervention: Control stores (no change in product placement)
Number of subjects: 108
Study 34264943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention stores
Number of subjects: 108
Study 34264943 — intervention group
Group type: COMPARATOR
Intervention: Control stores
Number of subjects: 108
Study 34264943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention stores (Phase II with enhanced intervention)
Number of subjects: 108
Study 34321303 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategy-based intervention (14 face-to-face sessions, 60 minutes each) focusing on text-level reading comprehension.
Number of subjects: 24
Study 34321303 — intervention group
Group type: COMPARATOR
Intervention: Waiting period (control group).
Number of subjects: 24
Study 36267853 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiuwei Zhenxin granules (single drug group)
Number of subjects: 710
Study 36267853 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiuwei Zhenxin granules and alprazolam (combination group)
Number of subjects: 710
Study 36267853 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned, but implied as the combination treatment)
Number of subjects: 710
Study 35865520 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 301
Study 35865520 — intervention group
Group type: COMPARATOR
Intervention: Placebo vaccination
Number of subjects: 301
Study 34553670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative mapping of lymphatic leakage with peri-incisional methylene blue injection and clipping of lymphatics
Number of subjects: 39
Study 34553670 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 35745249 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat biscuits enriched with plant proteins (PB)
Number of subjects: 70
Study 35745249 — intervention group
Group type: COMPARATOR
Intervention: Conventional wheat biscuits (CB)
Number of subjects: 70
Study 33630712 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 61
Study 33630712 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 61
Study 33630712 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic + Resistance Training (A+RT)
Number of subjects: 61
Study 33630712 — intervention group
Group type: COMPARATOR
Intervention: Control (CONT)
Number of subjects: 61
Study 32826390 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncovered stent
Number of subjects: 60
Study 32826390 — intervention group
Group type: COMPARATOR
Intervention: Covered stent
Number of subjects: 60
Study 35221689 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic aortobifemoral bypass (LABFB)
Number of subjects: 71
Study 35221689 — intervention group
Group type: COMPARATOR
Intervention: Open aortobifemoral bypass (OABFB)
Number of subjects: 71
Study 33016169 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment and Hall Technique (ART‐HT)
Number of subjects: 338
Study 33016169 — intervention group
Group type: COMPARATOR
Intervention: Usual care options (control)
Number of subjects: 338
Study 33136625 — intervention group
Group type: EXPERIMENTAL
Intervention: O‐WARRM (100 words)
Number of subjects: 72
Study 33136625 — intervention group
Group type: EXPERIMENTAL
Intervention: E‐WARRM (20 words, 5 runs)
Number of subjects: 72
Study 33136625 — intervention group
Group type: EXPERIMENTAL
Intervention: Run 1 of the E‐WARRM
Number of subjects: 72
Study 33136625 — intervention group
Group type: EXPERIMENTAL
Intervention: All five runs from the three E‐WARRM randomizations
Number of subjects: 72
Study 34979361 — intervention group
Group type: EXPERIMENTAL
Intervention: Community‐based Bilingual Doulas (CBDs)
Number of subjects: 35
Study 34049574 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 151
Study 34049574 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-3L
Number of subjects: 151
Study 35652236 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing by secondary intention without planned postoperative compression
Number of subjects: 58
Study 35652236 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound infections
Number of subjects: 58
Study 35652236 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital admissions
Number of subjects: 58
Study 33089408 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg temozolomide capsules (TOZ309)
Number of subjects: 29
Study 33089408 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-mg temozolomide capsules (TOZ309)
Number of subjects: 29
Study 33089408 — intervention group
Group type: COMPARATOR
Intervention: Temodal® capsules
Number of subjects: 29
Study 33089408 — intervention group
Group type: EXPERIMENTAL
Intervention: Both TOZ309 and Temodal®
Number of subjects: 29
Study 36415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 334
Study 36415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoupling (DC)
Number of subjects: 334
Study 36415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Decoupling in sensu (DC-is)
Number of subjects: 334
Study 36415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent application of multiple techniques
Number of subjects: 334
Study 36415779 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard DC and HRT
Number of subjects: 334
Study 36415779 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 334
Study 33058277 — intervention group
Group type: EXPERIMENTAL
Intervention: ESS-P
Number of subjects: 57
Study 33058277 — intervention group
Group type: COMPARATOR
Intervention: Minimally enhanced treatment as usual (Control)
Number of subjects: 57
Study 32781263 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintilimab 200 mg plus pemetrexed and platinum
Number of subjects: 397
Study 32781263 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus pemetrexed and platinum
Number of subjects: 397
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal, standardized, high-fidelity toddler screening
Number of subjects: 3450
Study 33934719 — intervention group
Group type: COMPARATOR
Intervention: Usual care ASD detection strategies
Number of subjects: 3450
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Start Denver Model intervention
Number of subjects: 3450
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: ASD symptom severity measured by Brief Observation of Social Communication Change (BOSCC)
Number of subjects: 3450
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive functioning measured by Mullen Scales of Early Learning (MSEL) and Differential Abilities Scale‐II (DAS‐II)
Number of subjects: 3450
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive functioning, ASD symptoms, and kindergarten readiness
Number of subjects: 3450
Study 33934719 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent stress and empowerment
Number of subjects: 3450
Study 33797479 — intervention group
Group type: EXPERIMENTAL
Intervention: Generation 7 Combat Application Tourniquet (CAT)
Number of subjects: 0
Study 33797479 — intervention group
Group type: EXPERIMENTAL
Intervention: Tactical Mechanical Tourniquet (TMT)
Number of subjects: 0
Study 33797479 — intervention group
Group type: EXPERIMENTAL
Intervention: SOF Tactical Tourniquet-Wide (SOFTT-W)
Number of subjects: 0
Study 33797479 — intervention group
Group type: COMPARATOR
Intervention: All tourniquets after subject maneuvers
Number of subjects: 0
Study 34613358 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin and steroids
Number of subjects: 100
Study 34613358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 32204155 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to the recitation of Qur'an (Ar-Rahman surah)
Number of subjects: 40
Study 32204155 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study 32569130 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional (TR) set configuration
Number of subjects: 31
Study 32569130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster (CL) set configuration
Number of subjects: 31
Study 32569130 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest Redistribution (RR) set configuration
Number of subjects: 31
Study 32569130 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 31
Study 34323055 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP medium used during embryo transfer (ET)
Number of subjects: 312
Study 34323055 — intervention group
Group type: COMPARATOR
Intervention: No ASP medium used during embryo transfer (ET)
Number of subjects: 312
Study 33337659 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenapanor 50 mg b.i.d.
Number of subjects: 620